Company Filing History:
Years Active: 2025
Title: Anna Hansen: Innovator in Autoimmune Disease Treatment
Introduction
Anna Hansen is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of biomedical research, particularly in the development of therapies for autoimmune and inflammatory diseases. Her innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Anna Hansen holds a patent for "Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases." This patent includes anti-FLT3L antibodies and outlines methods for using these antibodies to treat various autoimmune and inflammatory conditions. The patent represents a significant advancement in therapeutic options for patients suffering from these diseases. She has 1 patent to her name.
Career Highlights
Anna is currently employed at Horizon Therapeutics Ireland DAC, where she continues her research and development efforts. Her work at Horizon Therapeutics focuses on innovative solutions that aim to improve patient outcomes in the realm of autoimmune diseases.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including Xiaodong Xiao and Peter Pavlik. These collaborations have further enhanced her research and contributed to the advancement of therapeutic strategies in her field.
Conclusion
Anna Hansen is a trailblazer in the field of autoimmune disease treatment, with her innovative patent paving the way for new therapeutic approaches. Her dedication to research and collaboration with esteemed colleagues underscores her commitment to improving healthcare outcomes.